< Back to All Resources
In this case-control study of 34?505 Medicare beneficiaries, patients had greater risk of experiencing an opioid overdose and had higher health care expenditures in buprenorphine treatment gap months compared with treated months.
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2796738